Related Experiment Videos
Structure-activity relationships in the acronycine series
Sylvie Michel1, Elisabeth Seguin, Fraņois Tillequin
1Laboratoire de Pharmacognosie de l'Université René Descartes, U.M.R. / C.N.R.S. Faculté des Sciences Pharmaceutiques et Biologiques, 4, Avenue de l'Observatoire, Paris, F-75006, France.
Current Medicinal Chemistry
|August 13, 2002
Summary
Acronycine shows broad activity against solid tumors. New derivatives, 1,2-dihydroxy-1,2-dihydroacronycine diesters, demonstrated enhanced potency compared to the original compound.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Acronycine is an established compound with activity against various solid tumors.
- Structure-activity relationship studies highlighted the importance of the 1,2-double bond for acronycine's efficacy.
Purpose of the Study:
- To explore the bioactivation pathway of acronycine.
- To synthesize and evaluate novel acronycine derivatives with potentially enhanced anti-tumor activity.
Main Methods:
- Hypothesized bioactivation of acronycine to a 1,2-epoxide intermediate.
- Synthesized 1,2-dihydroxy-1,2-dihydroacronycine and 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diesters.
- Compared the in vitro potency of novel derivatives against the parent compound.
Main Results:
- The 1,2-double bond was identified as critical for acronycine's activity.
- Novel diester derivatives showed increased potency relative to acronycine.
- The bioactivation hypothesis guided the development of more potent analogs.
Conclusions:
- The bioactivation of acronycine to a 1,2-epoxide is a plausible mechanism.
- 1,2-dihydroxy-1,2-dihydroacronycine diesters represent a promising class of compounds with improved anti-cancer potential.